Recursion Pharmaceuticals stock has potential for huge returns with risk; speculative investment.

From Nasdaq: 2024-06-02 03:40:00

Investors dream of making a million dollars on a single stock, and Nvidia (NVDA) has made that dream a reality for some. $8,000 invested in 2016 would be worth $1 million today. However, most stocks won’t see such massive gains. Recursion Pharmaceuticals (RXRX) has potential, with Nvidia investing $50 million for AI drug discovery.

Recursion is a risky investment with huge upside potential, as seen when Nvidia’s investment caused the stock to soar. However, without proven results, it remains speculative. If the AI model is successful, there’s a chance for huge returns, but transforming healthcare is no easy feat. Investors should approach with caution.

The Motley Fool Stock Advisor team does not currently recommend investing in Recursion Pharmaceuticals. While the stock has potential for growth, the risk is high without concrete evidence of success. The 10 best stocks identified by the team have the potential for significant returns, offering a safer investment opportunity for those looking to build a successful portfolio.



Read more at Nasdaq: Is Recursion Pharmaceuticals Stock a Millionaire-Maker?